PPLPHARMA.NS
PPLPHARMA.NS
INE0DK501011
PIRAMAL PHARMA LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 87.588.200.000 90.610.000.000
3.3%
Cost of Revenue 35.836.300.000 35.721.300.000
0.3%
Gross Profit 51.751.900.000 54.888.700.000
5.7%
50.202.800.000 48.102.200.000
4.4%
Operating Income 1.549.100.000 6.786.500.000
77.2%
Pretax Income -1.760.600.000 4.146.400.000
142.5%
Net Income Common Stockholders -3.259.400.000 911.300.000
457.7%
-- --
--
-- --
--
ende